New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
06:10 EDTRAREUltragenyx Pharmaceuticals 5.76M share IPO priced at $21.00
The deal size was increased to 5.76M shares from 4.83M shares and priced above the $19.00-$20.00 range. JPMorgan and Morgan Stanley acted as joint book running managers for the offering.
News For RARE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 24, 2015
09:03 EDTRAREUltragenyx adds Orexigen CEO to board
Ultragenyx Pharmaceutical (RARE) announced the appointment of Michael Narachi to the company's board, effective February 20. Narachi, President and CEO and a director of Orexigen Therapeutics (OREX), will serve as an independent director to Ultragenyx.
February 23, 2015
07:22 EDTRARESunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use